172 related articles for article (PubMed ID: 23138836)
1. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.
Oyomopito RA; Li PC; Sungkanuparph S; Phanuphak P; Tee KK; Sirisanthana T; Kantipong P; Oka S; Lee CK; Kamarulzaman A; Choi JY; Sohn AH; Law M; Chen YM;
J Acquir Immune Defic Syndr; 2013 Mar; 62(3):293-300. PubMed ID: 23138836
[TBL] [Abstract][Full Text] [Related]
2. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).
Oyomopito R; Lee MP; Phanuphak P; Lim PL; Ditangco R; Zhou J; Sirisanthana T; Chen YM; Pujari S; Kumarasamy N; Sungkanuparph S; Lee CK; Kamarulzaman A; Oka S; Zhang FJ; Mean CV; Merati T; Tau G; Smith J; Li PC;
HIV Med; 2010 Sep; 11(8):519-29. PubMed ID: 20345881
[TBL] [Abstract][Full Text] [Related]
3. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
Geretti AM; Harrison L; Green H; Sabin C; Hill T; Fearnhill E; Pillay D; Dunn D;
Clin Infect Dis; 2009 May; 48(9):1296-305. PubMed ID: 19331585
[TBL] [Abstract][Full Text] [Related]
4. After 18 months of antiretroviral therapy, total HIV DNA decreases more pronouncedly in patients infected by CRF01_AE than in those infected by subtype B and CRF07_BC.
Lu Z; Jiao Y; Li J; Lan G; Lu C; Li X; Tang Z; Wang N
Microbiol Immunol; 2018 Apr; 62(4):248-254. PubMed ID: 29377267
[TBL] [Abstract][Full Text] [Related]
5. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
Ng OT; Lin L; Laeyendecker O; Quinn TC; Sun YJ; Lee CC; Leo YS
PLoS One; 2011 Jan; 6(1):e15738. PubMed ID: 21298051
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
[TBL] [Abstract][Full Text] [Related]
8. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
Scherrer AU; Ledergerber B; von Wyl V; Böni J; Yerly S; Klimkait T; Bürgisser P; Rauch A; Hirschel B; Cavassini M; Elzi L; Vernazza PL; Bernasconi E; Held L; Günthard HF;
Clin Infect Dis; 2011 Dec; 53(11):1143-52. PubMed ID: 21998284
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
Li X; Margolick JB; Jamieson BD; Rinaldo CR; Phair JP; Jacobson LP
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):421-8. PubMed ID: 21602699
[TBL] [Abstract][Full Text] [Related]
10. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
Touloumi G; Pantazis N; Chaix ML; Bucher HC; Zangerle R; Kran AM; Thiebaut R; Masquelier B; Kucherer C; Monforte Ad; Meyer L; Porter K;
PLoS One; 2013; 8(7):e71174. PubMed ID: 23936260
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals.
Li K; Chen H; Li J; Feng Y; Lan G; Liang S; Liu M; Rashid A; Xing H; Shen Z; Shao Y
Emerg Microbes Infect; 2022 Dec; 11(1):158-167. PubMed ID: 34895083
[TBL] [Abstract][Full Text] [Related]
12. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
[TBL] [Abstract][Full Text] [Related]
13. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
[TBL] [Abstract][Full Text] [Related]
15. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates.
Phuphuakrat A; Phawattanakul S; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
HIV Med; 2014 May; 15(5):269-75. PubMed ID: 24215399
[TBL] [Abstract][Full Text] [Related]
16. Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection.
Leelawiwat W; Pattanasin S; Sriporn A; Wasinrapee P; Kongpechsatit O; Mueanpai F; Tongtoyai J; Holtz TH; Curlin ME
PLoS One; 2018; 13(7):e0201386. PubMed ID: 30063722
[TBL] [Abstract][Full Text] [Related]
17. Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China.
Cui H; Geng W; Sun H; Han X; An M; Jiang Y; Zhang Z; Chen Z; Xu J; Hu Q; Zhao B; Zhou B; Shang H
AIDS; 2019 Jan; 33(1):13-22. PubMed ID: 30102662
[TBL] [Abstract][Full Text] [Related]
18. Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.
Paraskevis D; Touloumi G; Bakoyannis G; Paparizos V; Lazanas M; Gargalianos P; Chryssos G; Antoniadou A; Psichogiou M; Panos G; Katsarou O; Sambatakou H; Kordossis T; Hatzakis A;
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):461-9. PubMed ID: 23034083
[TBL] [Abstract][Full Text] [Related]
19. [HIV genetic subtypes and comparison of the first CD(4)(+)T cell counts in newly diagnosed HIV infected patients in Liuzhou, 1998-2012].
Cao ZQ; Yang WM; Zhu QY; Lan GH; Shen ZY; Liang SS; Li JJ; Chen HH; Feng Y; He X; Liao LJ; Xing H; Ruan YH; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):580-584. PubMed ID: 31177742
[No Abstract] [Full Text] [Related]
20. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
